Trevi Therapeutics Aktie
11,18
USD
-0,03
USD
-0,27
%
11,19
USD
-0,03
USD
-0,24
%
Werbung
Trevi Therapeutics Aktie Analyse
| 03.06.19 | Trevi Therapeutics Outperform | BMO Capital Markets | |
| 03.06.19 | Trevi Therapeutics Buy | Needham & Company, LLC |
Werbung
Werbung